Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Multi-Centre, Parallel, Double-Blind, Blinded Evaluator, Randomised, Placebo-Controlled Evaluation of the Efficacy and Safety of a Single Dose of 6 mL of Synvisc in Patients with Symptomatic Osteoarthritis of the Knee
Hylan G-F 20
SYNV00704
NCT00131352
Osteoarthritis, knee
Phase 3
 
Datasets and document are available as per Sanofi Policy and criteria
June 2017

Powered by ideaPoint, Inc.